Evidence map›Paper›PMID 36608155›Full record

ArticlePLoS neglected tropical diseases2023

Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort.

Carolina Dos Santos Lázari, Mariana Severo Ramundo, Felipe Ten-Caten, Clarisse S Bressan, Ana Maria Bispo de Filippis, Erika Regina Manuli, Isabella de Moraes, Geovana Maria Pereira, Marina Farrel Côrtes, Darlan da Silva Candido and 8 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Characterization of the clinical forms of chronic chikungunya: an observational cohort study in Rio de Janeiro.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Observational
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Carolina Dos Santos LázariHospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Mariana Severo RamundoDepartamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-0650-4985
Felipe Ten-CatenDepartamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Clarisse S BressanInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Ana Maria Bispo de FilippisInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Erika Regina ManuliDepartamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Isabella de MoraesInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Geovana Maria PereiraDepartamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Marina Farrel CôrtesDepartamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Darlan da Silva CandidoDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Alexandra L GerberLABINFO, Laboratório Nacional de Computação Científica, Petrópolis, Rio de Janeiro, Brazil.
Ana Paula GuimarãesLABINFO, Laboratório Nacional de Computação Científica, Petrópolis, Rio de Janeiro, Brazil.
Nuno Rodrigues FariaDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Helder I NakayaScientific Platform Pasteur, Universidade de São Paulo, São Paulo, Brazil.
Ana Tereza R VasconcelosLABINFO, Laboratório Nacional de Computação Científica, Petrópolis, Rio de Janeiro, Brazil.
Patrícia BrasilInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Gláucia Paranhos-BaccalàOpen Innovation and Partnerships, bioMérieux SA, Lyon, France.
Ester Cerdeira SabinoDepartamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRInstituto Evandro Chagas · BRLaboratório Nacional de Computação Científica · BRUniversity of Oxford · GBbioMérieux (France) · FRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BR

Funding

Medical Research Council MR/R015600/1Medical Research Council MR/S019510/1Wellcome TrustWellcome Trust 204311/Z/16/Z
6 · The paper itself

Abstract

backgroundChikungunya-fever (CHIKF) remains a public health major issue. It is clinically divided into three phases: acute, post-acute and chronic. Chronic cases correspond to 25-40% individuals and, though most of them are characterized by long-lasting arthralgia alone, many of them exhibit persistent or recurrent inflammatory signs that define post-Chikungunya chronic inflammatory joint disease (pCHIKV-CIJD). We aimed to identify early clinical markers of evolution to pCHIKV-CIJD during acute and post-acute phases. METHODOLOGY/PRINCIPAL

findingsWe studied a prospective cohort of CHIKF-confirmed volunteers with longitudinal clinical data collection from symptoms onset up to 90 days, including a 21-day visit (D21). Of 169 patients with CHIKF, 86 (50.9%) completed the follow-up, from whom 39 met clinical criteria for pCHIKV-CIJD (45.3%). The relative risk of chronification was higher in women compared to men (RR = 1.52; 95% CI = 1.15-1.99; FDR = 0.03). None of the symptoms or signs presented at D0 behaved as an early predictor of pCHIKV-CIJD, while being symptomatic at D21 was a risk factor for chronification (RR = 1.31; 95% CI = 1.09-1.55; FDR = 0.03). Significance was also observed for joint pain (RR = 1.35; 95% CI = 1.12-1.61; FDR = 0.02), reported edema (RR = 3.61; 95% CI = 1.44-9.06; FDR = 0.03), reported hand and/or feet small joints edema (RR = 4.22; 95% CI = 1.51-11.78; FDR = 0.02), and peri-articular edema observed during physical examination (RR = 2.89; 95% CI = 1.58-5.28; FDR = 0.002). Furthermore, patients with no findings in physical examination at D21 were at lower risk of chronic evolution (RR = 0.41, 95% CI = 0.24-0.70, FDR = 0.01). Twenty-nine pCHIKV-CIJD patients had abnormal articular ultrasonography (90.6% of the examined). The most common findings were synovitis (65.5%) and joint effusion (58.6%).

conclusionThis cohort has provided important insights into the prognostic evaluation of CHIKF. Symptomatic sub-acute disease is a relevant predictor of evolution to chronic arthritis with synovitis, drawing attention to joint pain, edema, multiple articular involvement including small hand and feet joints as risk factors for chronification beyond three months, especially in women. Future studies are needed to accomplish the identification of accurate and early biomarkers of poor clinical prognosis, which would allow better understanding of the disease's evolution and improve patients' management, modifying CHIKF burden on global public health.

Indexed as

ArthritisChikungunya FeverSynovitisArthralgiaBiomarkersBrazilChronic DiseaseFemaleHumansMaleProspective StudiesBiomarkers

Identifiers

PMID36608155
PMCPMC9851532
OpenAlexW4313598722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.